Literature DB >> 21565915

Properties of the COPD assessment test in a cross-sectional European study.

P W Jones1, G Brusselle, R W Dal Negro, M Ferrer, P Kardos, M L Levy, T Perez, J J Soler Cataluña, T van der Molen, L Adamek, N Banik.   

Abstract

A short, easy-to-use health status questionnaire is needed in the multidimensional assessment of chronic obstructive pulmonary disease (COPD) in routine practice. The performance of the eight-item COPD assessment test (CAT) was analysed in 1,817 patients from primary care in seven European countries. The CAT has a scoring range of 0-40 (high score representing poor health status). Mean CAT scores indicated significant health status impairment that was related to severity of airway obstruction, but within each Global Initiative for Obstructive Lung Disease stage (I to IV) there was a wide range of scores (I: 16.2 ± 8.8; II: 16.3 ± 7.9; III: 19.3 ± 8.2; and IV: 22.3 ± 8.7; I versus II, p = 0.88; II versus III, p<0.0001; III versus IV, p = 0.0001). CAT scores showed relatively little variability across countries (within ± 12% of the mean across all countries). Scores were significantly better in patients who were stable (17.2 ± 8.3) versus those suffering an exacerbation (21.3 ± 8.4) (p<0.0001); and in patients with no (17.3 ± 8.1) or one or two (16.6 ± 8.2) versus three or more (19.7 ± 8.5) comorbidities (p<0.0001 for both). The CAT distinguished between classes of other impairment measures and was strongly correlated with the St George's Respiratory Questionnaire (r = 0.8, p<0.0001). The CAT is a simple and easy-to-use questionnaire that distinguishes between patients of different degrees of COPD severity and appears to behave the same way across countries.

Entities:  

Mesh:

Year:  2011        PMID: 21565915     DOI: 10.1183/09031936.00177210

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  131 in total

1.  Chronic lung disease in adult recurrent tuberculosis survivors in Zimbabwe: a cohort study.

Authors:  A T Chin; J Rylance; S Makumbirofa; S Meffert; T Vu; J Clayton; P Mason; P Woodruff; J Metcalfe
Journal:  Int J Tuberc Lung Dis       Date:  2019-02-01       Impact factor: 2.373

2.  Does the COPD assessment test (CAT(TM)) questionnaire produce similar results when self- or interviewer administered?

Authors:  A Agusti; J J Soler-Cataluña; J Molina; E Morejon; M Garcia-Losa; M Roset; X Badia
Journal:  Qual Life Res       Date:  2015-04-07       Impact factor: 4.147

3.  Six-minute-walk distance and accelerometry predict outcomes in chronic obstructive pulmonary disease independent of Global Initiative for Chronic Obstructive Lung Disease 2011 Group.

Authors:  Michael T Durheim; Patrick J Smith; Michael A Babyak; Stephanie K Mabe; Tereza Martinu; Karen E Welty-Wolf; Charles F Emery; Scott M Palmer; James A Blumenthal
Journal:  Ann Am Thorac Soc       Date:  2015-03

4.  Effectiveness of pharmaceutical care for patients with chronic obstructive pulmonary disease (PHARMACOP): a randomized controlled trial.

Authors:  Eline Tommelein; Els Mehuys; Thierry Van Hees; Els Adriaens; Luc Van Bortel; Thierry Christiaens; Inge Van Tongelen; Jean-Paul Remon; Koen Boussery; Guy Brusselle
Journal:  Br J Clin Pharmacol       Date:  2014-05       Impact factor: 4.335

5.  Psychometric Properties of the COPD-Specific Beliefs About Medicine Questionnaire in an Outpatient Population: A Rasch-Analysis.

Authors:  Marie Topp; Jørgen Vestbo; Erik Lykke Mortensen
Journal:  Chronic Obstr Pulm Dis       Date:  2016-09-02

6.  Effect of Tiotropium on Outcomes in Patients With COPD, Categorized Using the New GOLD Grading System: Results of the UPLIFT® Randomized Controlled Trial.

Authors:  David M G Halpin; Donald P Tashkin; Bartolome R Celli; Inge Leimer; Norbert Metzdorf; Marc Decramer
Journal:  Chronic Obstr Pulm Dis       Date:  2015-06-23

Review 7.  Progress in Characterizing Patient-Centered Outcomes in COPD, 2004-2014.

Authors:  Paul Jones
Journal:  Chronic Obstr Pulm Dis       Date:  2014-05-06

8.  GOLD 2011 disease severity classification in COPDGene: a prospective cohort study.

Authors:  MeiLan K Han; Hana Muellerova; Douglas Curran-Everett; Mark T Dransfield; George R Washko; Elizabeth A Regan; Russell P Bowler; Terri H Beaty; John E Hokanson; David A Lynch; Paul W Jones; Antonio Anzueto; Fernando J Martinez; James D Crapo; Edwin K Silverman; Barry J Make
Journal:  Lancet Respir Med       Date:  2012-09-03       Impact factor: 30.700

9.  Evolution of the COPD Assessment Test score during chronic obstructive pulmonary disease exacerbations: determinants and prognostic value.

Authors:  Darwin Feliz-Rodriguez; Santiago Zudaire; Carlos Carpio; Elizabet Martínez; Antonia Gómez-Mendieta; Ana Santiago; Rodolfo Alvarez-Sala; Francisco García-Río
Journal:  Can Respir J       Date:  2013 Sep-Oct       Impact factor: 2.409

10.  Patient-centred assessment of COPD in primary care: experience from a cross-sectional study of health-related quality of life in Europe.

Authors:  Paul W Jones; Guy Brusselle; Roberto W Dal Negro; Montse Ferrer; Peter Kardos; Mark L Levy; Thierry Perez; Juan José Soler Cataluña; Thys van der Molen; Lukasz Adamek; Norbert Banik
Journal:  Prim Care Respir J       Date:  2012-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.